Title:
METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
Document Type and Number:
Japanese Patent JP2015083612
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation.SOLUTION: This invention relates to a method for treating central nervous system disease using a combination of a muscarine activator and a muscarine inhibitor, and an agent comprising the muscarine activator and the muscarine inhibitor.
Inventors:
ERIC ELENKO
ANDREW C MILLER
PHILIP E MURRAY III
ANDREW C MILLER
PHILIP E MURRAY III
Application Number:
JP2015016246A
Publication Date:
April 30, 2015
Filing Date:
January 30, 2015
Export Citation:
Assignee:
PURETECH VENTURES
International Classes:
A61K45/06; A61K9/02; A61K9/06; A61K9/08; A61K9/10; A61K9/12; A61K9/20; A61K9/48; A61P25/14; A61P25/18; A61P25/24; A61P25/28
Domestic Patent References:
JP2005530742A | 2005-10-13 | |||
JP2009507021A | 2009-02-19 | |||
JPH1059848A | 1998-03-03 | |||
JP2012519704A | 2012-08-30 |
Foreign References:
DE19612504A1 | 1997-08-21 | |||
US20050250767A1 | 2005-11-10 | |||
US20080114014A1 | 2008-05-15 |
Other References:
JPN6014031951; Neurotoxicol Teratol 17(3), 1995, 289-95
Attorney, Agent or Firm:
Yoshiyuki Inaba
Toshifumi Onuki
Toshifumi Onuki
Previous Patent: METHOD OF TREATING HEMOLYTIC DISEASE
Next Patent: CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF
Next Patent: CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF